Penile cancer: Clinical Practice Guidelines in Oncology

Autor: Pe, Clark, Pe, Spiess, Agarwal N, Mc, Biagioli, Ma, Eisenberger, Re, Greenberg, Hw, Herr, Brant Inman, Da, Kuban, Tm, Kuzel, Sm, Lele, Michalski J, Pagliaro L, Sk, Pal, Patterson A, Er, Plimack, Ks, Pohar, Mp, Porter, Jp, Richie, Wj, Sexton, Wu, Shipley, Ej, Small, Dl, Trump, Wile G, Tg, Wilson, Dwyer M, Ho M, National Comprehensive Cancer Network

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN, vol 11, iss 5
Europe PubMed Central

Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the United States and other developed countries. Although rare, it is associated with significant disfigurement, and only half of the patients survive beyo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::45f74b36421d90ce911e21a5393f1bde
https://escholarship.org/uc/item/53d840zs

Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour.

Autor: Antonelli L; Department of Urology, Luzerner Kantonsspital, University of Lucerne, Lucerne, Switzerland.; Department of Urology, Policlinico Umberto I, Sapienza University, Rome, Italy., Heidenreich A; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Department of Urology, Medical University, Vienna, Austria., Bagrodia A; Department of Urology, Univerity of California, San Diego, CA, USA.; The University of Texas Southwestern, Dallas, TX, USA., Amini A; Department of Urology, Univerity of California, San Diego, CA, USA.; The University of Texas Southwestern, Dallas, TX, USA., Baky F; Department of Urology, Univerity of California, San Diego, CA, USA.; The University of Texas Southwestern, Dallas, TX, USA., Branger N; Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France., Cazzaniga W; Department of Urology, The Royal Marsden NHS Foundation Trust, London, Sutton, UK., Clinton TN; Department of Urology, Brigham and Women's Hospital, Boston, MA, USA., Daneshmand S; Institute of Urology, Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA., Djaladat H; Institute of Urology, Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA., Eggener S; Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, IL, USA., Ghoreifi A; Institute of Urology, Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA., Hamilton RJ; Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Ho M; Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, IL, USA., Sexton WJ; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Nazzani S; Urologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Nicol D; Department of Urology, The Royal Marsden NHS Foundation Trust, London, Sutton, UK.; Institute of Cancer Research, London, UK., Nicolai N; Urologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Olson K; Department of Urology, Mayo Clinic, Scottsdale, AZ, USA., Paffenholz P; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Porter J; Department of Urology, University of Washington School of Medicine, Seattle, WA, USA., Qian Z; Department of Urology, Brigham and Women's Hospital, Boston, MA, USA., Rocco NR; Department of Urology, Naval Medical Center, San Diego, CA, USA., Yerrapragada A; Department of Urology and Oncology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Stroup SP; Department of Urology, Naval Medical Center, San Diego, CA, USA., Tachibana I; Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA., Terbuch A; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Singla N; Department of Urology and Oncology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cary C; Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA., Fankhauser CD; Department of Urology, Luzerner Kantonsspital, University of Lucerne, Lucerne, Switzerland.; University of Zurich, Zurich, Switzerland.

Publikováno v: BJU international [BJU Int] 2024 Dec 11. Date of Electronic Publication: 2024 Dec 11.

Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.

Autor: Li R; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Roger.Li@moffitt.org.; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Roger.Li@moffitt.org., Villa NY; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Yu X; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Johnson JO; Analytic Microscopy Core, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Borjas G; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Dhillon J; Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Moran-Segura CM; Advanced Analytical and Digital Laboratory, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Kim Y; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Francis N; Tissue Core, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Dorman D; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Powers JJ; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Sexton WJ; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Poch MA; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Zemp L; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Gilbert SM; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Zhang J; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Pow-Sang JM; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Anderson ARA; Department of Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Li T; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Wang X; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Grass GD; Department of Radiation Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Burke JM; Big Horn Basin Cancer Center, Cody, WY, USA., Dinney CPN; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rodriguez PC; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Jain RK; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Mulé JJ; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Conejo-Garcia JR; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Department of Integrative Immunobiology, Duke School of Medicine, Durham, NC, USA.

Publikováno v: Nature medicine [Nat Med] 2024 Nov 09. Date of Electronic Publication: 2024 Nov 09.

From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer.

Autor: Linscott JA; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Joshua.linscott@moffitt.org., Miyagi H; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Murthy PB; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Yao S; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Grass GD; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Vosoughi A; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Xu H; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Wang X; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Yu X; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Yu A; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Zemp L; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Gilbert SM; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Poch MA; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sexton WJ; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Spiess PE; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Li R; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Publikováno v: Current oncology reports [Curr Oncol Rep] 2024 Aug; Vol. 26 (8), pp. 945-958. Date of Electronic Publication: 2024 Jun 05.

NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.

Autor: Flaig TW; 1University of Colorado Cancer Center., Spiess PE; 2Moffitt Cancer Center., Abern M; 3Duke Cancer Institute., Agarwal N; 4Huntsman Cancer Institute at the University of Utah., Bangs R; 5Patient Advocate., Buyyounouski MK; 6Stanford Cancer Institute., Chan K; 7City of Hope National Medical Center., Chang SS; 8Vanderbilt-Ingram Cancer Center., Chang P; 9The UChicago Medicine Comprehensive Cancer Center., Friedlander T; 10UCSF Helen Diller Family Comprehensive Cancer Center., Greenberg RE; 11Fox Chase Cancer Center., Guru KA; 12Roswell Park Comprehensive Cancer Center., Herr HW; 13Memorial Sloan Kettering Cancer Center., Hoffman-Censits J; 14The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Kaimakliotis H; 15Indiana University Melvin and Bren Simon Comprehensive Cancer Center., Kishan AU; 16UCLA Jonsson Comprehensive Cancer Center., Kundu S; 17Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Lele SM; 18Fred & Pamela Buffett Cancer Center., Mamtani R; 19Abramson Cancer Center at the University of Pennsylvania., Mian OY; 20Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Michalski J; 21Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., Montgomery JS; 22University of Michigan Rogel Cancer Center., Parikh M; 23UC Davis Comprehensive Cancer Center., Patterson A; 24St. Jude Children's Research Hospital/The University of Tennessee Health Science Center., Peyton C; 25O'Neal Comprehensive Cancer Center at UAB., Plimack ER; 11Fox Chase Cancer Center., Preston MA; 26Dana-Farber/Brigham and Women's Cancer Center., Richards K; 27University of Wisconsin Carbone Cancer Center., Sexton WJ; 2Moffitt Cancer Center., Siefker-Radtke AO; 28The University of Texas MD Anderson Cancer Center., Stewart T; 29UC San Diego Moores Cancer Center., Sundi D; 30The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Tollefson M; 31Mayo Clinic Comprehensive Cancer Center., Tward J; 4Huntsman Cancer Institute at the University of Utah., Wright JL; 32Fred Hutchinson Cancer Center., Cassara CJ; 33National Comprehensive Cancer Network., Gurski LA; 33National Comprehensive Cancer Network.

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 May; Vol. 22 (4), pp. 216-225.